Steven L. Barriere
Directeur Technique/Scientifique/R&D chez Theravance Biopharma US, Inc.
Profil
Steven L.
Barriere is currently a Clinical Professor at The University of California, San Francisco and a Vice President-Clinical & Medical Affairs at Theravance Biopharma US, Inc. He previously worked as a Vice President-Clinical & Medical Affairs at Innoviva, Inc. He holds a doctorate degree from The University of California, San Francisco.
Postes actifs de Steven L. Barriere
| Sociétés | Poste | Début |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 25/03/2009 |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Steven L. Barriere
| Sociétés | Poste | Fin |
|---|---|---|
| INNOVIVA, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Steven L. Barriere
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
